nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0333	0.0482	CbGbCtD
Fluvoxamine—CYP3A7—Dapsone—systemic lupus erythematosus	0.0333	0.0482	CbGbCtD
Fluvoxamine—CYP2E1—Dapsone—systemic lupus erythematosus	0.0321	0.0465	CbGbCtD
Fluvoxamine—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0261	0.0378	CbGbCtD
Fluvoxamine—CYP3A5—Dapsone—systemic lupus erythematosus	0.025	0.0362	CbGbCtD
Fluvoxamine—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0235	0.034	CbGbCtD
Fluvoxamine—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.0232	0.0335	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.0232	0.0335	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.0219	0.0317	CbGbCtD
Fluvoxamine—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.0219	0.0317	CbGbCtD
Fluvoxamine—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0216	0.0314	CbGbCtD
Fluvoxamine—CYP2C19—Dapsone—systemic lupus erythematosus	0.0201	0.0292	CbGbCtD
Fluvoxamine—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0186	0.0269	CbGbCtD
Fluvoxamine—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.018	0.0261	CbGbCtD
Fluvoxamine—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0174	0.0252	CbGbCtD
Fluvoxamine—CYP2C9—Dapsone—systemic lupus erythematosus	0.0167	0.0243	CbGbCtD
Fluvoxamine—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0164	0.0238	CbGbCtD
Fluvoxamine—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.0144	0.0209	CbGbCtD
Fluvoxamine—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.0144	0.0209	CbGbCtD
Fluvoxamine—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0141	0.0204	CbGbCtD
Fluvoxamine—CYP2C19—Prednisone—systemic lupus erythematosus	0.014	0.0202	CbGbCtD
Fluvoxamine—CYP2E1—Dexamethasone—systemic lupus erythematosus	0.0139	0.0201	CbGbCtD
Fluvoxamine—CYP2B6—Dexamethasone—systemic lupus erythematosus	0.0137	0.0199	CbGbCtD
Fluvoxamine—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0132	0.0192	CbGbCtD
Fluvoxamine—ABCB1—Betamethasone—systemic lupus erythematosus	0.0121	0.0175	CbGbCtD
Fluvoxamine—ABCB1—Prednisolone—systemic lupus erythematosus	0.0119	0.0173	CbGbCtD
Fluvoxamine—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0113	0.0164	CbGbCtD
Fluvoxamine—ABCB1—Prednisone—systemic lupus erythematosus	0.0113	0.0163	CbGbCtD
Fluvoxamine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0111	0.0161	CbGbCtD
Fluvoxamine—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.011	0.0159	CbGbCtD
Fluvoxamine—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0108	0.0156	CbGbCtD
Fluvoxamine—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0107	0.0155	CbGbCtD
Fluvoxamine—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0101	0.0146	CbGbCtD
Fluvoxamine—CYP2C9—cardial valve—systemic lupus erythematosus	0.00998	0.173	CbGeAlD
Fluvoxamine—CYP3A4—Dapsone—systemic lupus erythematosus	0.00973	0.0141	CbGbCtD
Fluvoxamine—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00871	0.0126	CbGbCtD
Fluvoxamine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00844	0.0122	CbGbCtD
Fluvoxamine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00844	0.0122	CbGbCtD
Fluvoxamine—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00724	0.0105	CbGbCtD
Fluvoxamine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00724	0.0105	CbGbCtD
Fluvoxamine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00714	0.0104	CbGbCtD
Fluvoxamine—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00703	0.0102	CbGbCtD
Fluvoxamine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00677	0.00981	CbGbCtD
Fluvoxamine—CYP3A4—Prednisone—systemic lupus erythematosus	0.00675	0.00977	CbGbCtD
Fluvoxamine—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00662	0.0096	CbGbCtD
Fluvoxamine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0064	0.00927	CbGbCtD
Fluvoxamine—ABCB1—Methotrexate—systemic lupus erythematosus	0.00565	0.00818	CbGbCtD
Fluvoxamine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00421	0.0061	CbGbCtD
Fluvoxamine—CYP2C19—urine—systemic lupus erythematosus	0.00278	0.0482	CbGeAlD
Fluvoxamine—CYP1A2—urine—systemic lupus erythematosus	0.00227	0.0394	CbGeAlD
Fluvoxamine—CYP2C9—urine—systemic lupus erythematosus	0.00215	0.0374	CbGeAlD
Fluvoxamine—CYP2E1—urine—systemic lupus erythematosus	0.00204	0.0355	CbGeAlD
Fluvoxamine—SLC6A4—blood plasma—systemic lupus erythematosus	0.00175	0.0304	CbGeAlD
Fluvoxamine—CYP3A4—urine—systemic lupus erythematosus	0.00164	0.0285	CbGeAlD
Fluvoxamine—CYP2D6—urine—systemic lupus erythematosus	0.00162	0.0281	CbGeAlD
Fluvoxamine—CYP2C19—blood plasma—systemic lupus erythematosus	0.00145	0.0252	CbGeAlD
Fluvoxamine—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.00142	0.0247	CbGeAlD
Fluvoxamine—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.00122	0.0212	CbGeAlD
Fluvoxamine—CYP1A2—blood plasma—systemic lupus erythematosus	0.00118	0.0206	CbGeAlD
Fluvoxamine—CYP3A5—blood plasma—systemic lupus erythematosus	0.00114	0.0198	CbGeAlD
Fluvoxamine—CYP2B6—blood plasma—systemic lupus erythematosus	0.00113	0.0197	CbGeAlD
Fluvoxamine—CYP2C9—blood plasma—systemic lupus erythematosus	0.00112	0.0195	CbGeAlD
Fluvoxamine—CYP2E1—blood plasma—systemic lupus erythematosus	0.00106	0.0185	CbGeAlD
Fluvoxamine—SIGMAR1—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000982	1	CbGdCrCtD
Fluvoxamine—SIGMAR1—nephron tubule—systemic lupus erythematosus	0.000896	0.0156	CbGeAlD
Fluvoxamine—CYP3A4—blood plasma—systemic lupus erythematosus	0.000857	0.0149	CbGeAlD
Fluvoxamine—CYP2D6—blood plasma—systemic lupus erythematosus	0.000843	0.0146	CbGeAlD
Fluvoxamine—SIGMAR1—cortex of kidney—systemic lupus erythematosus	0.000767	0.0133	CbGeAlD
Fluvoxamine—SIGMAR1—tendon—systemic lupus erythematosus	0.000636	0.011	CbGeAlD
Fluvoxamine—SIGMAR1—bone marrow—systemic lupus erythematosus	0.000616	0.0107	CbGeAlD
Fluvoxamine—SLC6A3—lung—systemic lupus erythematosus	0.000613	0.0107	CbGeAlD
Fluvoxamine—ABCB1—blood plasma—systemic lupus erythematosus	0.000607	0.0105	CbGeAlD
Fluvoxamine—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000589	0.0102	CbGeAlD
Fluvoxamine—CYP2B6—nephron tubule—systemic lupus erythematosus	0.000585	0.0102	CbGeAlD
Fluvoxamine—SLC6A3—nervous system—systemic lupus erythematosus	0.000568	0.00986	CbGeAlD
Fluvoxamine—SLC6A4—lung—systemic lupus erythematosus	0.000562	0.00976	CbGeAlD
Fluvoxamine—CYP1A1—skin of body—systemic lupus erythematosus	0.000561	0.00975	CbGeAlD
Fluvoxamine—SIGMAR1—lung—systemic lupus erythematosus	0.000558	0.00969	CbGeAlD
Fluvoxamine—CYP2E1—nephron tubule—systemic lupus erythematosus	0.000549	0.00954	CbGeAlD
Fluvoxamine—SLC6A3—central nervous system—systemic lupus erythematosus	0.000547	0.0095	CbGeAlD
Fluvoxamine—CYP2B6—skin of body—systemic lupus erythematosus	0.000546	0.00948	CbGeAlD
Fluvoxamine—CYP1A1—kidney—systemic lupus erythematosus	0.000529	0.00919	CbGeAlD
Fluvoxamine—SLC6A4—nervous system—systemic lupus erythematosus	0.00052	0.00904	CbGeAlD
Fluvoxamine—CYP3A5—kidney—systemic lupus erythematosus	0.000518	0.00899	CbGeAlD
Fluvoxamine—CYP2B6—kidney—systemic lupus erythematosus	0.000514	0.00894	CbGeAlD
Fluvoxamine—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000504	0.00876	CbGeAlD
Fluvoxamine—SLC6A4—central nervous system—systemic lupus erythematosus	0.000501	0.0087	CbGeAlD
Fluvoxamine—CYP2E1—kidney—systemic lupus erythematosus	0.000483	0.00839	CbGeAlD
Fluvoxamine—CYP2E1—cortex of kidney—systemic lupus erythematosus	0.00047	0.00817	CbGeAlD
Fluvoxamine—CYP2B6—lymphoid tissue—systemic lupus erythematosus	0.000442	0.00767	CbGeAlD
Fluvoxamine—CYP2E1—lymphoid tissue—systemic lupus erythematosus	0.000415	0.0072	CbGeAlD
Fluvoxamine—CYP2E1—tendon—systemic lupus erythematosus	0.00039	0.00677	CbGeAlD
Fluvoxamine—CYP3A4—kidney—systemic lupus erythematosus	0.000388	0.00675	CbGeAlD
Fluvoxamine—CYP2D6—kidney—systemic lupus erythematosus	0.000382	0.00664	CbGeAlD
Fluvoxamine—CYP1A2—lung—systemic lupus erythematosus	0.00038	0.0066	CbGeAlD
Fluvoxamine—CYP1A1—lung—systemic lupus erythematosus	0.000375	0.00652	CbGeAlD
Fluvoxamine—CYP3A5—lung—systemic lupus erythematosus	0.000367	0.00637	CbGeAlD
Fluvoxamine—CYP2B6—lung—systemic lupus erythematosus	0.000364	0.00633	CbGeAlD
Fluvoxamine—CYP1A1—nervous system—systemic lupus erythematosus	0.000347	0.00603	CbGeAlD
Fluvoxamine—CYP2E1—lung—systemic lupus erythematosus	0.000342	0.00594	CbGeAlD
Fluvoxamine—CYP2B6—nervous system—systemic lupus erythematosus	0.000337	0.00586	CbGeAlD
Fluvoxamine—CYP1A1—central nervous system—systemic lupus erythematosus	0.000334	0.00581	CbGeAlD
Fluvoxamine—CYP2B6—central nervous system—systemic lupus erythematosus	0.000325	0.00564	CbGeAlD
Fluvoxamine—CYP2E1—nervous system—systemic lupus erythematosus	0.000317	0.0055	CbGeAlD
Fluvoxamine—ABCB1—nephron tubule—systemic lupus erythematosus	0.000313	0.00543	CbGeAlD
Fluvoxamine—CYP2E1—central nervous system—systemic lupus erythematosus	0.000305	0.0053	CbGeAlD
Fluvoxamine—ABCB1—kidney—systemic lupus erythematosus	0.000275	0.00478	CbGeAlD
Fluvoxamine—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000268	0.00465	CbGeAlD
Fluvoxamine—CYP3A4—nervous system—systemic lupus erythematosus	0.000255	0.00443	CbGeAlD
Fluvoxamine—CYP2D6—nervous system—systemic lupus erythematosus	0.000251	0.00436	CbGeAlD
Fluvoxamine—CYP3A4—central nervous system—systemic lupus erythematosus	0.000245	0.00426	CbGeAlD
Fluvoxamine—CYP2D6—central nervous system—systemic lupus erythematosus	0.000241	0.00419	CbGeAlD
Fluvoxamine—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000236	0.0041	CbGeAlD
Fluvoxamine—ABCB1—bone marrow—systemic lupus erythematosus	0.000215	0.00374	CbGeAlD
Fluvoxamine—ABCB1—lung—systemic lupus erythematosus	0.000195	0.00338	CbGeAlD
Fluvoxamine—ABCB1—nervous system—systemic lupus erythematosus	0.00018	0.00313	CbGeAlD
Fluvoxamine—ABCB1—central nervous system—systemic lupus erythematosus	0.000174	0.00302	CbGeAlD
Fluvoxamine—Fatigue—Hydrocortisone—systemic lupus erythematosus	6.89e-05	0.000274	CcSEcCtD
Fluvoxamine—Vision blurred—Prednisone—systemic lupus erythematosus	6.87e-05	0.000273	CcSEcCtD
Fluvoxamine—Urethral disorder—Methotrexate—systemic lupus erythematosus	6.86e-05	0.000273	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	6.86e-05	0.000273	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	6.84e-05	0.000272	CcSEcCtD
Fluvoxamine—Pain—Hydrocortisone—systemic lupus erythematosus	6.83e-05	0.000272	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	6.83e-05	0.000272	CcSEcCtD
Fluvoxamine—Oedema—Betamethasone—systemic lupus erythematosus	6.83e-05	0.000272	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	6.83e-05	0.000272	CcSEcCtD
Fluvoxamine—Oedema—Dexamethasone—systemic lupus erythematosus	6.83e-05	0.000272	CcSEcCtD
Fluvoxamine—Insomnia—Triamcinolone—systemic lupus erythematosus	6.81e-05	0.000271	CcSEcCtD
Fluvoxamine—Insomnia—Methylprednisolone—systemic lupus erythematosus	6.79e-05	0.00027	CcSEcCtD
Fluvoxamine—Infection—Betamethasone—systemic lupus erythematosus	6.78e-05	0.00027	CcSEcCtD
Fluvoxamine—Infection—Dexamethasone—systemic lupus erythematosus	6.78e-05	0.00027	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	6.76e-05	0.000269	CcSEcCtD
Fluvoxamine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	6.76e-05	0.000269	CcSEcCtD
Fluvoxamine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	6.74e-05	0.000268	CcSEcCtD
Fluvoxamine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	6.74e-05	0.000268	CcSEcCtD
Fluvoxamine—Visual impairment—Methotrexate—systemic lupus erythematosus	6.74e-05	0.000268	CcSEcCtD
Fluvoxamine—Anaemia—Prednisone—systemic lupus erythematosus	6.73e-05	0.000268	CcSEcCtD
Fluvoxamine—Shock—Betamethasone—systemic lupus erythematosus	6.72e-05	0.000267	CcSEcCtD
Fluvoxamine—Shock—Dexamethasone—systemic lupus erythematosus	6.72e-05	0.000267	CcSEcCtD
Fluvoxamine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	6.71e-05	0.000267	CcSEcCtD
Fluvoxamine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	6.7e-05	0.000267	CcSEcCtD
Fluvoxamine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	6.7e-05	0.000267	CcSEcCtD
Fluvoxamine—Agitation—Prednisone—systemic lupus erythematosus	6.7e-05	0.000267	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	6.69e-05	0.000266	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	6.69e-05	0.000266	CcSEcCtD
Fluvoxamine—Tachycardia—Dexamethasone—systemic lupus erythematosus	6.66e-05	0.000265	CcSEcCtD
Fluvoxamine—Tachycardia—Betamethasone—systemic lupus erythematosus	6.66e-05	0.000265	CcSEcCtD
Fluvoxamine—Angioedema—Prednisone—systemic lupus erythematosus	6.66e-05	0.000265	CcSEcCtD
Fluvoxamine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	6.63e-05	0.000264	CcSEcCtD
Fluvoxamine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	6.62e-05	0.000264	CcSEcCtD
Fluvoxamine—Erythema multiforme—Methotrexate—systemic lupus erythematosus	6.61e-05	0.000263	CcSEcCtD
Fluvoxamine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	6.61e-05	0.000263	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	6.6e-05	0.000263	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	6.6e-05	0.000263	CcSEcCtD
Fluvoxamine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	6.59e-05	0.000262	CcSEcCtD
Fluvoxamine—Malaise—Prednisone—systemic lupus erythematosus	6.57e-05	0.000262	CcSEcCtD
Fluvoxamine—Vertigo—Prednisone—systemic lupus erythematosus	6.55e-05	0.000261	CcSEcCtD
Fluvoxamine—Eye disorder—Methotrexate—systemic lupus erythematosus	6.54e-05	0.00026	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	6.54e-05	0.00026	CcSEcCtD
Fluvoxamine—Syncope—Prednisone—systemic lupus erythematosus	6.53e-05	0.00026	CcSEcCtD
Fluvoxamine—Tinnitus—Methotrexate—systemic lupus erythematosus	6.52e-05	0.00026	CcSEcCtD
Fluvoxamine—Anorexia—Dexamethasone—systemic lupus erythematosus	6.51e-05	0.000259	CcSEcCtD
Fluvoxamine—Anorexia—Betamethasone—systemic lupus erythematosus	6.51e-05	0.000259	CcSEcCtD
Fluvoxamine—Urticaria—Prednisolone—systemic lupus erythematosus	6.5e-05	0.000259	CcSEcCtD
Fluvoxamine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	6.49e-05	0.000258	CcSEcCtD
Fluvoxamine—Fatigue—Triamcinolone—systemic lupus erythematosus	6.49e-05	0.000258	CcSEcCtD
Fluvoxamine—Fatigue—Methylprednisolone—systemic lupus erythematosus	6.47e-05	0.000258	CcSEcCtD
Fluvoxamine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	6.46e-05	0.000257	CcSEcCtD
Fluvoxamine—Asthenia—Cyclosporine—systemic lupus erythematosus	6.45e-05	0.000257	CcSEcCtD
Fluvoxamine—Pain—Triamcinolone—systemic lupus erythematosus	6.44e-05	0.000256	CcSEcCtD
Fluvoxamine—Loss of consciousness—Prednisone—systemic lupus erythematosus	6.4e-05	0.000255	CcSEcCtD
Fluvoxamine—Hypotension—Dexamethasone—systemic lupus erythematosus	6.38e-05	0.000254	CcSEcCtD
Fluvoxamine—Hypotension—Betamethasone—systemic lupus erythematosus	6.38e-05	0.000254	CcSEcCtD
Fluvoxamine—Pruritus—Cyclosporine—systemic lupus erythematosus	6.36e-05	0.000253	CcSEcCtD
Fluvoxamine—Urticaria—Hydrocortisone—systemic lupus erythematosus	6.35e-05	0.000253	CcSEcCtD
Fluvoxamine—Angiopathy—Methotrexate—systemic lupus erythematosus	6.35e-05	0.000253	CcSEcCtD
Fluvoxamine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	6.32e-05	0.000251	CcSEcCtD
Fluvoxamine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	6.32e-05	0.000251	CcSEcCtD
Fluvoxamine—Convulsion—Prednisone—systemic lupus erythematosus	6.31e-05	0.000251	CcSEcCtD
Fluvoxamine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	6.29e-05	0.000251	CcSEcCtD
Fluvoxamine—Hypertension—Prednisone—systemic lupus erythematosus	6.29e-05	0.00025	CcSEcCtD
Fluvoxamine—Chills—Methotrexate—systemic lupus erythematosus	6.28e-05	0.00025	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	6.22e-05	0.000248	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	6.22e-05	0.000248	CcSEcCtD
Fluvoxamine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	6.21e-05	0.000247	CcSEcCtD
Fluvoxamine—Myalgia—Prednisone—systemic lupus erythematosus	6.2e-05	0.000247	CcSEcCtD
Fluvoxamine—Arthralgia—Prednisone—systemic lupus erythematosus	6.2e-05	0.000247	CcSEcCtD
Fluvoxamine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	6.2e-05	0.000247	CcSEcCtD
Fluvoxamine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	6.19e-05	0.000246	CcSEcCtD
Fluvoxamine—Anxiety—Prednisone—systemic lupus erythematosus	6.18e-05	0.000246	CcSEcCtD
Fluvoxamine—Alopecia—Methotrexate—systemic lupus erythematosus	6.18e-05	0.000246	CcSEcCtD
Fluvoxamine—Insomnia—Dexamethasone—systemic lupus erythematosus	6.18e-05	0.000246	CcSEcCtD
Fluvoxamine—Insomnia—Betamethasone—systemic lupus erythematosus	6.18e-05	0.000246	CcSEcCtD
Fluvoxamine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	6.15e-05	0.000245	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	6.14e-05	0.000244	CcSEcCtD
Fluvoxamine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	6.13e-05	0.000244	CcSEcCtD
Fluvoxamine—Paraesthesia—Betamethasone—systemic lupus erythematosus	6.13e-05	0.000244	CcSEcCtD
Fluvoxamine—Discomfort—Prednisone—systemic lupus erythematosus	6.13e-05	0.000244	CcSEcCtD
Fluvoxamine—Mental disorder—Methotrexate—systemic lupus erythematosus	6.13e-05	0.000244	CcSEcCtD
Fluvoxamine—Malnutrition—Methotrexate—systemic lupus erythematosus	6.09e-05	0.000242	CcSEcCtD
Fluvoxamine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	6.03e-05	0.00024	CcSEcCtD
Fluvoxamine—Dyspepsia—Betamethasone—systemic lupus erythematosus	6.01e-05	0.000239	CcSEcCtD
Fluvoxamine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	6.01e-05	0.000239	CcSEcCtD
Fluvoxamine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	6e-05	0.000239	CcSEcCtD
Fluvoxamine—Urticaria—Triamcinolone—systemic lupus erythematosus	5.98e-05	0.000238	CcSEcCtD
Fluvoxamine—Urticaria—Methylprednisolone—systemic lupus erythematosus	5.96e-05	0.000237	CcSEcCtD
Fluvoxamine—Dysgeusia—Methotrexate—systemic lupus erythematosus	5.96e-05	0.000237	CcSEcCtD
Fluvoxamine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	5.95e-05	0.000237	CcSEcCtD
Fluvoxamine—Dizziness—Cyclosporine—systemic lupus erythematosus	5.95e-05	0.000237	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	5.95e-05	0.000237	CcSEcCtD
Fluvoxamine—Oedema—Prednisone—systemic lupus erythematosus	5.95e-05	0.000237	CcSEcCtD
Fluvoxamine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	5.94e-05	0.000236	CcSEcCtD
Fluvoxamine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	5.94e-05	0.000236	CcSEcCtD
Fluvoxamine—Decreased appetite—Betamethasone—systemic lupus erythematosus	5.94e-05	0.000236	CcSEcCtD
Fluvoxamine—Infection—Prednisone—systemic lupus erythematosus	5.91e-05	0.000235	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	5.89e-05	0.000235	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	5.89e-05	0.000235	CcSEcCtD
Fluvoxamine—Back pain—Methotrexate—systemic lupus erythematosus	5.89e-05	0.000234	CcSEcCtD
Fluvoxamine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	5.89e-05	0.000234	CcSEcCtD
Fluvoxamine—Fatigue—Dexamethasone—systemic lupus erythematosus	5.89e-05	0.000234	CcSEcCtD
Fluvoxamine—Fatigue—Betamethasone—systemic lupus erythematosus	5.89e-05	0.000234	CcSEcCtD
Fluvoxamine—Shock—Prednisone—systemic lupus erythematosus	5.85e-05	0.000233	CcSEcCtD
Fluvoxamine—Pain—Dexamethasone—systemic lupus erythematosus	5.84e-05	0.000232	CcSEcCtD
Fluvoxamine—Pain—Betamethasone—systemic lupus erythematosus	5.84e-05	0.000232	CcSEcCtD
Fluvoxamine—Nervous system disorder—Prednisone—systemic lupus erythematosus	5.83e-05	0.000232	CcSEcCtD
Fluvoxamine—Tachycardia—Prednisone—systemic lupus erythematosus	5.8e-05	0.000231	CcSEcCtD
Fluvoxamine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	5.8e-05	0.000231	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	5.75e-05	0.000229	CcSEcCtD
Fluvoxamine—Vision blurred—Methotrexate—systemic lupus erythematosus	5.74e-05	0.000228	CcSEcCtD
Fluvoxamine—Asthenia—Hydrocortisone—systemic lupus erythematosus	5.73e-05	0.000228	CcSEcCtD
Fluvoxamine—Vomiting—Cyclosporine—systemic lupus erythematosus	5.72e-05	0.000228	CcSEcCtD
Fluvoxamine—Rash—Cyclosporine—systemic lupus erythematosus	5.67e-05	0.000226	CcSEcCtD
Fluvoxamine—Anorexia—Prednisone—systemic lupus erythematosus	5.67e-05	0.000226	CcSEcCtD
Fluvoxamine—Dermatitis—Cyclosporine—systemic lupus erythematosus	5.66e-05	0.000225	CcSEcCtD
Fluvoxamine—Pruritus—Hydrocortisone—systemic lupus erythematosus	5.65e-05	0.000225	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	5.65e-05	0.000225	CcSEcCtD
Fluvoxamine—Headache—Cyclosporine—systemic lupus erythematosus	5.63e-05	0.000224	CcSEcCtD
Fluvoxamine—Anaemia—Methotrexate—systemic lupus erythematosus	5.63e-05	0.000224	CcSEcCtD
Fluvoxamine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	5.63e-05	0.000224	CcSEcCtD
Fluvoxamine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	5.63e-05	0.000224	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	5.58e-05	0.000222	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	5.58e-05	0.000222	CcSEcCtD
Fluvoxamine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.58e-05	0.000222	CcSEcCtD
Fluvoxamine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	5.54e-05	0.000221	CcSEcCtD
Fluvoxamine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	5.53e-05	0.00022	CcSEcCtD
Fluvoxamine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	5.53e-05	0.00022	CcSEcCtD
Fluvoxamine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	5.53e-05	0.00022	CcSEcCtD
Fluvoxamine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	5.5e-05	0.000219	CcSEcCtD
Fluvoxamine—Malaise—Methotrexate—systemic lupus erythematosus	5.49e-05	0.000219	CcSEcCtD
Fluvoxamine—Vertigo—Methotrexate—systemic lupus erythematosus	5.47e-05	0.000218	CcSEcCtD
Fluvoxamine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.47e-05	0.000218	CcSEcCtD
Fluvoxamine—Leukopenia—Methotrexate—systemic lupus erythematosus	5.45e-05	0.000217	CcSEcCtD
Fluvoxamine—Urticaria—Dexamethasone—systemic lupus erythematosus	5.42e-05	0.000216	CcSEcCtD
Fluvoxamine—Urticaria—Betamethasone—systemic lupus erythematosus	5.42e-05	0.000216	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	5.42e-05	0.000216	CcSEcCtD
Fluvoxamine—Dizziness—Prednisolone—systemic lupus erythematosus	5.41e-05	0.000215	CcSEcCtD
Fluvoxamine—Asthenia—Triamcinolone—systemic lupus erythematosus	5.4e-05	0.000215	CcSEcCtD
Fluvoxamine—Abdominal pain—Betamethasone—systemic lupus erythematosus	5.4e-05	0.000215	CcSEcCtD
Fluvoxamine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	5.4e-05	0.000215	CcSEcCtD
Fluvoxamine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	5.4e-05	0.000215	CcSEcCtD
Fluvoxamine—Body temperature increased—Betamethasone—systemic lupus erythematosus	5.4e-05	0.000215	CcSEcCtD
Fluvoxamine—Asthenia—Methylprednisolone—systemic lupus erythematosus	5.39e-05	0.000214	CcSEcCtD
Fluvoxamine—Insomnia—Prednisone—systemic lupus erythematosus	5.38e-05	0.000214	CcSEcCtD
Fluvoxamine—Nausea—Cyclosporine—systemic lupus erythematosus	5.34e-05	0.000213	CcSEcCtD
Fluvoxamine—Paraesthesia—Prednisone—systemic lupus erythematosus	5.34e-05	0.000213	CcSEcCtD
Fluvoxamine—Pruritus—Triamcinolone—systemic lupus erythematosus	5.32e-05	0.000212	CcSEcCtD
Fluvoxamine—Cough—Methotrexate—systemic lupus erythematosus	5.31e-05	0.000212	CcSEcCtD
Fluvoxamine—Pruritus—Methylprednisolone—systemic lupus erythematosus	5.31e-05	0.000211	CcSEcCtD
Fluvoxamine—Dizziness—Hydrocortisone—systemic lupus erythematosus	5.28e-05	0.00021	CcSEcCtD
Fluvoxamine—Convulsion—Methotrexate—systemic lupus erythematosus	5.28e-05	0.00021	CcSEcCtD
Fluvoxamine—Dyspepsia—Prednisone—systemic lupus erythematosus	5.23e-05	0.000208	CcSEcCtD
Fluvoxamine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	5.21e-05	0.000207	CcSEcCtD
Fluvoxamine—Myalgia—Methotrexate—systemic lupus erythematosus	5.18e-05	0.000206	CcSEcCtD
Fluvoxamine—Arthralgia—Methotrexate—systemic lupus erythematosus	5.18e-05	0.000206	CcSEcCtD
Fluvoxamine—Chest pain—Methotrexate—systemic lupus erythematosus	5.18e-05	0.000206	CcSEcCtD
Fluvoxamine—Decreased appetite—Prednisone—systemic lupus erythematosus	5.17e-05	0.000206	CcSEcCtD
Fluvoxamine—Rash—Prednisolone—systemic lupus erythematosus	5.16e-05	0.000205	CcSEcCtD
Fluvoxamine—Dermatitis—Prednisolone—systemic lupus erythematosus	5.15e-05	0.000205	CcSEcCtD
Fluvoxamine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	5.14e-05	0.000205	CcSEcCtD
Fluvoxamine—Fatigue—Prednisone—systemic lupus erythematosus	5.13e-05	0.000204	CcSEcCtD
Fluvoxamine—Headache—Prednisolone—systemic lupus erythematosus	5.13e-05	0.000204	CcSEcCtD
Fluvoxamine—Discomfort—Methotrexate—systemic lupus erythematosus	5.12e-05	0.000204	CcSEcCtD
Fluvoxamine—Constipation—Prednisone—systemic lupus erythematosus	5.08e-05	0.000202	CcSEcCtD
Fluvoxamine—Vomiting—Hydrocortisone—systemic lupus erythematosus	5.08e-05	0.000202	CcSEcCtD
Fluvoxamine—Rash—Hydrocortisone—systemic lupus erythematosus	5.04e-05	0.000201	CcSEcCtD
Fluvoxamine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	5.03e-05	0.0002	CcSEcCtD
Fluvoxamine—Confusional state—Methotrexate—systemic lupus erythematosus	5.01e-05	0.000199	CcSEcCtD
Fluvoxamine—Headache—Hydrocortisone—systemic lupus erythematosus	5.01e-05	0.000199	CcSEcCtD
Fluvoxamine—Dizziness—Triamcinolone—systemic lupus erythematosus	4.98e-05	0.000198	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	4.97e-05	0.000198	CcSEcCtD
Fluvoxamine—Dizziness—Methylprednisolone—systemic lupus erythematosus	4.97e-05	0.000198	CcSEcCtD
Fluvoxamine—Infection—Methotrexate—systemic lupus erythematosus	4.94e-05	0.000197	CcSEcCtD
Fluvoxamine—Feeling abnormal—Prednisone—systemic lupus erythematosus	4.9e-05	0.000195	CcSEcCtD
Fluvoxamine—Asthenia—Dexamethasone—systemic lupus erythematosus	4.9e-05	0.000195	CcSEcCtD
Fluvoxamine—Asthenia—Betamethasone—systemic lupus erythematosus	4.9e-05	0.000195	CcSEcCtD
Fluvoxamine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	4.87e-05	0.000194	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.87e-05	0.000194	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	4.86e-05	0.000194	CcSEcCtD
Fluvoxamine—Nausea—Prednisolone—systemic lupus erythematosus	4.86e-05	0.000193	CcSEcCtD
Fluvoxamine—Pruritus—Dexamethasone—systemic lupus erythematosus	4.83e-05	0.000192	CcSEcCtD
Fluvoxamine—Pruritus—Betamethasone—systemic lupus erythematosus	4.83e-05	0.000192	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	4.8e-05	0.000191	CcSEcCtD
Fluvoxamine—Vomiting—Triamcinolone—systemic lupus erythematosus	4.78e-05	0.00019	CcSEcCtD
Fluvoxamine—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.77e-05	0.00019	CcSEcCtD
Fluvoxamine—Nausea—Hydrocortisone—systemic lupus erythematosus	4.75e-05	0.000189	CcSEcCtD
Fluvoxamine—Rash—Triamcinolone—systemic lupus erythematosus	4.74e-05	0.000189	CcSEcCtD
Fluvoxamine—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.74e-05	0.000189	CcSEcCtD
Fluvoxamine—Anorexia—Methotrexate—systemic lupus erythematosus	4.74e-05	0.000189	CcSEcCtD
Fluvoxamine—Rash—Methylprednisolone—systemic lupus erythematosus	4.73e-05	0.000188	CcSEcCtD
Fluvoxamine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.73e-05	0.000188	CcSEcCtD
Fluvoxamine—Urticaria—Prednisone—systemic lupus erythematosus	4.72e-05	0.000188	CcSEcCtD
Fluvoxamine—Headache—Triamcinolone—systemic lupus erythematosus	4.71e-05	0.000188	CcSEcCtD
Fluvoxamine—Headache—Methylprednisolone—systemic lupus erythematosus	4.7e-05	0.000187	CcSEcCtD
Fluvoxamine—Body temperature increased—Prednisone—systemic lupus erythematosus	4.7e-05	0.000187	CcSEcCtD
Fluvoxamine—Abdominal pain—Prednisone—systemic lupus erythematosus	4.7e-05	0.000187	CcSEcCtD
Fluvoxamine—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.67e-05	0.000186	CcSEcCtD
Fluvoxamine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.67e-05	0.000186	CcSEcCtD
Fluvoxamine—Hypotension—Methotrexate—systemic lupus erythematosus	4.64e-05	0.000185	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	4.53e-05	0.00018	CcSEcCtD
Fluvoxamine—Dizziness—Dexamethasone—systemic lupus erythematosus	4.52e-05	0.00018	CcSEcCtD
Fluvoxamine—Dizziness—Betamethasone—systemic lupus erythematosus	4.52e-05	0.00018	CcSEcCtD
Fluvoxamine—Insomnia—Methotrexate—systemic lupus erythematosus	4.49e-05	0.000179	CcSEcCtD
Fluvoxamine—Nausea—Triamcinolone—systemic lupus erythematosus	4.47e-05	0.000178	CcSEcCtD
Fluvoxamine—Paraesthesia—Methotrexate—systemic lupus erythematosus	4.46e-05	0.000178	CcSEcCtD
Fluvoxamine—Nausea—Methylprednisolone—systemic lupus erythematosus	4.46e-05	0.000178	CcSEcCtD
Fluvoxamine—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.43e-05	0.000176	CcSEcCtD
Fluvoxamine—Somnolence—Methotrexate—systemic lupus erythematosus	4.42e-05	0.000176	CcSEcCtD
Fluvoxamine—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.38e-05	0.000174	CcSEcCtD
Fluvoxamine—Dyspepsia—Methotrexate—systemic lupus erythematosus	4.37e-05	0.000174	CcSEcCtD
Fluvoxamine—Vomiting—Betamethasone—systemic lupus erythematosus	4.34e-05	0.000173	CcSEcCtD
Fluvoxamine—Vomiting—Dexamethasone—systemic lupus erythematosus	4.34e-05	0.000173	CcSEcCtD
Fluvoxamine—Decreased appetite—Methotrexate—systemic lupus erythematosus	4.32e-05	0.000172	CcSEcCtD
Fluvoxamine—Rash—Dexamethasone—systemic lupus erythematosus	4.31e-05	0.000171	CcSEcCtD
Fluvoxamine—Rash—Betamethasone—systemic lupus erythematosus	4.31e-05	0.000171	CcSEcCtD
Fluvoxamine—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.3e-05	0.000171	CcSEcCtD
Fluvoxamine—Dermatitis—Betamethasone—systemic lupus erythematosus	4.3e-05	0.000171	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	4.29e-05	0.000171	CcSEcCtD
Fluvoxamine—Fatigue—Methotrexate—systemic lupus erythematosus	4.28e-05	0.000171	CcSEcCtD
Fluvoxamine—Headache—Dexamethasone—systemic lupus erythematosus	4.28e-05	0.00017	CcSEcCtD
Fluvoxamine—Headache—Betamethasone—systemic lupus erythematosus	4.28e-05	0.00017	CcSEcCtD
Fluvoxamine—Asthenia—Prednisone—systemic lupus erythematosus	4.27e-05	0.00017	CcSEcCtD
Fluvoxamine—Pain—Methotrexate—systemic lupus erythematosus	4.25e-05	0.000169	CcSEcCtD
Fluvoxamine—Pruritus—Prednisone—systemic lupus erythematosus	4.21e-05	0.000167	CcSEcCtD
Fluvoxamine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	4.1e-05	0.000163	CcSEcCtD
Fluvoxamine—Diarrhoea—Prednisone—systemic lupus erythematosus	4.07e-05	0.000162	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	4.06e-05	0.000162	CcSEcCtD
Fluvoxamine—Nausea—Dexamethasone—systemic lupus erythematosus	4.06e-05	0.000161	CcSEcCtD
Fluvoxamine—Nausea—Betamethasone—systemic lupus erythematosus	4.06e-05	0.000161	CcSEcCtD
Fluvoxamine—Urticaria—Methotrexate—systemic lupus erythematosus	3.95e-05	0.000157	CcSEcCtD
Fluvoxamine—Dizziness—Prednisone—systemic lupus erythematosus	3.93e-05	0.000157	CcSEcCtD
Fluvoxamine—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.93e-05	0.000156	CcSEcCtD
Fluvoxamine—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.93e-05	0.000156	CcSEcCtD
Fluvoxamine—Vomiting—Prednisone—systemic lupus erythematosus	3.78e-05	0.00015	CcSEcCtD
Fluvoxamine—Rash—Prednisone—systemic lupus erythematosus	3.75e-05	0.000149	CcSEcCtD
Fluvoxamine—Dermatitis—Prednisone—systemic lupus erythematosus	3.75e-05	0.000149	CcSEcCtD
Fluvoxamine—Headache—Prednisone—systemic lupus erythematosus	3.73e-05	0.000148	CcSEcCtD
Fluvoxamine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.66e-05	0.000146	CcSEcCtD
Fluvoxamine—Asthenia—Methotrexate—systemic lupus erythematosus	3.57e-05	0.000142	CcSEcCtD
Fluvoxamine—Nausea—Prednisone—systemic lupus erythematosus	3.53e-05	0.000141	CcSEcCtD
Fluvoxamine—Pruritus—Methotrexate—systemic lupus erythematosus	3.52e-05	0.00014	CcSEcCtD
Fluvoxamine—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.4e-05	0.000135	CcSEcCtD
Fluvoxamine—Dizziness—Methotrexate—systemic lupus erythematosus	3.29e-05	0.000131	CcSEcCtD
Fluvoxamine—Vomiting—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000126	CcSEcCtD
Fluvoxamine—Rash—Methotrexate—systemic lupus erythematosus	3.13e-05	0.000125	CcSEcCtD
Fluvoxamine—Dermatitis—Methotrexate—systemic lupus erythematosus	3.13e-05	0.000125	CcSEcCtD
Fluvoxamine—Headache—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000124	CcSEcCtD
Fluvoxamine—Nausea—Methotrexate—systemic lupus erythematosus	2.95e-05	0.000118	CcSEcCtD
